Nicole is an investor at an early stage, thesis driven, frontier tech fund called Compound. She invests in all areas of frontier tech but is focused on digital health and personalized medicine, machine learning & federated learning, lab automation, game engines, and near term hybrid quantum classical algorithms and quantum sensing. Previously she worked with a startup running experimental educational initiatives to create hands-on learning experiences for under-represented groups to cutting edge STEM domains with organizations like NASA, DARPA, and the NIH; studied data science and worked at Capterra, a Gartner company. Nicole is based in NYC, and invests globally.

Nicole invests in all areas of frontier tech, but is focused on digital health and personalized medicine, as well as federated learning, lab automation, game engines, and near term hybrid quantum classical algorithms and quantum sensing.

We are a research-driven firm that likes technically challenging companies with GTM hypotheses. We differentiate ourselves by spending time reading technical research and partnering at the earliest stages of ideation to help build teams and help translate highly technical companies to more general investors later on. We will invest pre-product and pre-revenue and are happy to help form companies technical teams as long as the founder has researched hypotheses about technical product and GTM sequencing.